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Forward genetic screens are a method used to identify genes which are responsible for a particular 
phenotype. They have been used to identify many molecular components of the biochemical 
pathways that develop and maintain life. However, the identification of RNA interface (RNAi), a 
biological process by which RNA molecules inhibit gene expression, and other powerful genetic 
knock-down strategies, has made reverse genetic screens extremely popular. Reverse genetic 
screens start by disrupting a known gene, and then analyze the resultant phenotypes. Many forward 
genetic screens have been less fruitful given the difficulty in mapping causative mutations of a given 
phenotype. This is especially true in vertebrate models, where whole genome sequencing (popular 
with invertebrate screens) can be costly due to large genome sizes. The Moens’s Lab (Basic 
Sciences Division) recently developed a novel technique based on RNA-seq to provide a relatively 
cost effective way of identifying mutations from forward genetic screens. 
Under Dr. Moens’s guidance, Miller et al. devised an RNA-seq-based bulk segregant analysis (BSA) 
approach to identify the candidate mutations. BSA identifies regions of the genome that are linked to 
a mutation in a group of mutant animals. The researchers reasoned that next generation sequencing 
of RNA isolated from mutants would uncover single nucleotide polymorphisms (SNPs) that co-
segregate with the mutant phenotype and that would help to map mutations. Moreover, changes in 
mRNA transcript levels or splicing events would be revealed by the sequencing data and might 
therefore give the researcher a head start in discovering how the mutation might affect protein 
stability or function. 
As a proof of principle, Miller and colleagues used four already-established zebrafish mutants to test 
whether RNA-seq would effectively identify the genomic locus of the mutations. After crossing 
heterozygous mutants (to obtain wild-type siblings from the cross) and scoring for the phenotype of 
interest, RNA from wild-type and mutant embryo pools was extracted, and cDNA was prepared from 
the isolated mRNA to generate the sequencing libraries (see figure). By barcoding each pool with a 
unique sequence tag, a total of six libraries (three sibling/mutant pairs) were added to each lane of 
an Illumina HiSeq 2000 machine to generate an average of 43 million 50-base pair paired-end reads 
per sample. 
The reads from each sibling/mutant pair were aligned to the zebrafish genome using the 
TopHat/Bowtie program, and SNPs within the wild-type sequence were identified that could serve as 
markers to test for linkage within the mutant sequences. 40,000 high-confidence markers (SNPs) per 
experiment were identified that were used to determine if a particular genomic region was linked to 
the mutation of interest.  For instance, the SNP marker frequency at or proximal to the mutation will 
be 1 (all alleles are the same), with a decrease in frequency the farther away the SNP resides on the 
chromosome from the mutation. The researchers confirmed that their RNA-seq protocol successfully  
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identified the four known genetic lesions of their mutants. Increasing the number of embryos 
sequenced from 20 to 80 helped to decrease the linkage area, indicating that sequencing a 
moderate number of embryos can accurately pinpoint the genomic region of the responsible 
mutation. Moreover, the authors gathered that their RNA-seq approach could identify a reasonable 
number of SNP changes that could represent mutations of interest when mapping unknown mutants 
from genetic screens.  
Altogether, the development of an RNA-seq based mapping approach to identify candidate 
mutations from genetic screens has many advantages. RNA-seq is relatively inexpensive and 
effectively limits the genomic landscape sequenced since only expressed genes would be 
sequenced. Potential changes in RNA splicing due to mutations would be apparent within the 
sequenced datasets, as would changes in the expression level of genes linked to the mutation of 
interest. The authors have also developed an in silicobioinformatics pipeline (www.RNAmapper.org) 
to aid other researchers in their genetic mapping endeavors.  The novel RNA-seq method developed 
by Miller and colleagues will undoubtedly hasten the final steps in forward genetic screens to reveal 
mutations in genes that affect nearly every aspect of life. 
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Image obtained from the manuscript 
Figure: Diagram of the RNA-seq-based approach. A) Heterozygous 
animals (+/-) that have a mutation (red asterisk; grey bar represents 
chromosome linked to the mutation) are crossed to obtain wild-type and 
mutant embryo pools. B) The mutant pool will be homozygous for the 
mutation and also for SNPs proximal to the mutation (i.e. SNP2) but will 
be heterozygous at other SNPs (i.e. SNP1) due to meiotic recombination. 
C) The wild-type pool identifies SNP1 and SNP2, two polymorphisms 
useful for mapping. The sequence data from the mutants is then 
interrogated at the marker positions to identify homozygosity, indicating 
the identification of the candidate mutation. D) Plotting mutant marker 
frequency against chromosomal position reveals the region of linkage (red 
box). 
 
